EUVIMEDEUVIMED entdecken
Open Access

Allosensitisation in NHP results in cross‐reactive anti‐ SLA antibodies not detected by a lymphocyte‐based flow cytometry crossmatch

Joseph M Ladowski iD, Henry Chapman, Isabel DeLaura, Imran J Anwar iD, Janghoon Yoon, Zheng Chen, Adella Clark, DongFeng Chen, Stuart Knechtle, Annette Jackson, Bruce Rogers, Jean Kwun iD

HLA · 2024-07 · 104 (1)

DOI: 10.1111/tan.15599 ↗

Kurz gefasst

Fachartikel in der Zeitschrift HLA, online erschienen am 23.07.2024. Verfasst von Joseph M Ladowski und 11 weiteren Autor:innen. Beteiligte Einrichtung: Duke Transplant Center, Department of Surgery, Duke University School of Medicine, Durham, North Carolina, USA. Hauptthemen laut MEDLINE: Cross Reactions, Histocompatibility Testing, Flow Cytometry, Histocompatibility Antigens Class I. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIH HHS, NIAID NIH HHS, American Society of Transplant Surgeons (ASTS).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Xenotransplantation is a potential option for individuals for whom an acceptable human allograft is unavailable. Individuals with broadly reactive HLA antibodies due to prior exposure to foreign HLA are potential candidates for a clinical xenotransplant trial. It remains controversial if allosensitisation results in the development of cross‐reactive antibodies against SLA. This may require increased histocompatibility scrutiny for highly sensitised individuals prior to enrollment in a clinical trial. Serum samples were obtained from non‐human primates sensitised via serial skin transplantation from maximally MHC‐mismatched donor, as reported. Sera from pre‐ and post‐allosensitisation timepoints were assessed in a flow crossmatch (FXM) for IgM and IgG binding to pig splenocytes with or without red blood cell adsorption. Xenoreactive antibodies were eluted from pig splenocytes and screened on a single antigen HLA bead assay. A MHC Matchmaker algorithm was developed to predict potential conserved amino acid motifs among the pig, NHP, and human. Our sensitised NHP model was used to demonstrate that allosensitisation does not result in an appreciable difference in xenoreactive antibody binding in a cell‐based FXM. However, antibody elution and screening on single antigen HLA beads suggest the existence of potential cross‐reactive antibodies against SLA. The cross‐reactive IgG after allosensitisation were predicted by comparing the recipient Mamu alleles against its previous allograft donor Mamu alleles and the donor pig SLA alleles. Our study suggests that allosensitisation could elevate cross‐reactive antibodies, but a more sensitive assay than a cell‐based FXM is required to detect them. The MHC Matchmaker algorithm was developed as a potential tool to help determine amino acid motif conservation and reactivity pattern.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cross ReactionsHistocompatibility TestingFlow CytometryHistocompatibility Antigens Class IAnimalsHumansSwineImmunoglobulin GIsoantibodiesTransplantation, HeterologousHistocompatibility Antigens Class IISkin TransplantationImmunoglobulin MHLA AntigensLymphocytesAlgorithms

Stichwörter der Autor:innen

HLA matchmakeralloantibodyepitopesepletskidney transplantationsensitisationxenoreactive antibodyxenotransplantation

Substanzen

Histocompatibility Antigens Class IImmunoglobulin Gswine leukocyte antigenIsoantibodiesHistocompatibility Antigens Class IIImmunoglobulin MHLA Antigens

Autor:innen und Institutionen

  • Duke Transplant Center, Department of Surgery, Duke University School of Medicine, Durham, North Carolina, USA.
  • Department of Surgery, Duke University School of Medicine, Durham, North Carolina, USA.
  • Clinical Transplantation Immunology Laboratory, Duke University School of Medicine, Durham, North Carolina, USA.

ORCID-Profile: Joseph M Ladowski, Imran J Anwar, Jean Kwun

Förderung

  • NIH HHS
  • NIAID NIH HHS
  • American Society of Transplant Surgeons (ASTS)
  • National Institutes of Health

Zitieren

APA

Ladowski, J. M., Chapman, H., DeLaura, I., Anwar, I. J., Yoon, J., Chen, Z., Clark, A., Chen, D., Knechtle, S., Jackson, A., Rogers, B., & Kwun, J. (2024). Allosensitisation in NHP results in cross‐reactive anti‐ SLA antibodies not detected by a lymphocyte‐based flow cytometry crossmatch. HLA, 104(1). https://doi.org/10.1111/tan.15599

Vancouver

Ladowski JM, Chapman H, DeLaura I, Anwar IJ, Yoon J, Chen Z, et al. Allosensitisation in NHP results in cross‐reactive anti‐ SLA antibodies not detected by a lymphocyte‐based flow cytometry crossmatch. HLA. 2024;104(1). doi:10.1111/tan.15599

BibTeX
@article{Ladowski2024,
  author = {Ladowski, Joseph M and Chapman, Henry and DeLaura, Isabel and Anwar, Imran J and Yoon, Janghoon and Chen, Zheng and Clark, Adella and Chen, DongFeng and Knechtle, Stuart and Jackson, Annette and Rogers, Bruce and Kwun, Jean},
  title = {Allosensitisation in NHP results in cross‐reactive anti‐ SLA antibodies not detected by a lymphocyte‐based flow cytometry crossmatch},
  journal = {HLA},
  year = {2024},
  volume = {104},
  number = {1},
  doi = {10.1111/tan.15599}
}
Kostenlos starten →